Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 2cureX 2CUREX Sep 7, 2026 0.42 0.00   
 36 Group 36GRP Sep 7, 2026 0.11 +15.05   
 4C Group AB 4C Sep 7, 2026 7.30 -0.55   
 AAC Clyde Space AAC Sep 7, 2026 110.60 +0.36   
 AAK AAK Sep 7, 2026 204.60 -1.35   
 ABAS Protect AB ABAS Sep 7, 2026 8.65 +0.58   
 ABB ABB Sep 7, 2026 935.40 +2.12   
 Abelco Investment Group ABIG Sep 7, 2026 0.00 0.00   
 Abera Bioscience ABERA Sep 7, 2026 8.06 -0.49   
 Absolent Air Care Group ABSO Sep 7, 2026 205.00 +1.99   
 Absolicon B ABSLB Sep 7, 2026 2.74 -2.84   
 AcadeMedia ACAD Sep 7, 2026 101.40 +1.00   
 Acarix ACARIX Sep 7, 2026 0.23 -4.04   
 Acast ACAST Sep 7, 2026 35.25 +0.71   
 Acconeer ACCON Sep 7, 2026 15.52 -2.39   
 Acenta Group PADEL Sep 7, 2026 1.63 0.00   
 AcouSort ACOU Sep 7, 2026 2.90 -1.36   
 Acrinova A ACRIA Sep 7, 2026 8.56 -2.28   
 Acrinova B ACRIB Sep 7, 2026 7.64 -2.55   
 ACROUD ACROUD Sep 7, 2026 0.13 -5.11   
 Actic Group ATIC Sep 7, 2026 27.30 0.00   
 Active Biotech ACTI Sep 7, 2026 4.96 +0.92   
 AcuCort ACUC Sep 7, 2026 0.62 +0.65   
 Acuvi AB ACUVI Sep 7, 2026 8.27 -0.24   
 AddLife B ALIFB Sep 7, 2026 161.30 -1.35   
 Addnode Group B ANODB Sep 7, 2026 48.20 -0.10   
 Addtech B ADDTB Sep 7, 2026 333.40 +0.91   
 Adtraction ADTR Sep 7, 2026 40.40 -0.49   
 Advenica ADVE Sep 7, 2026 17.00 -0.47   
 Adverty ADVT Sep 7, 2026 0.20 +8.56   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.